These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9131006)

  • 1. Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis.
    Baird PN; Simmons PJ
    Exp Hematol; 1997 Apr; 25(4):312-20. PubMed ID: 9131006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro.
    Maurer U; Brieger J; Weidmann E; Mitrou PS; Hoelzer D; Bergmann L
    Exp Hematol; 1997 Aug; 25(9):945-50. PubMed ID: 9257807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
    Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
    Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Elimination of leukemic CD34+ progenitor cells by using cytotoxic T lymphocytes specifically targeting WT1-derived peptide: an experimental study in vitro].
    Gu WY; Chen ZX; Qiu GQ; Hu SY; Jia L; Wu W; He J; Cen JN; He B
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3401-6. PubMed ID: 19159569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
    Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
    Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of Wilms' tumor gene (WT1) in leukemias and its clinical implication].
    Wu X; Wang Y; Pei X
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):16-9. PubMed ID: 10921096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gene expression in small numbers of purified hemopoietic progenitor cells by RT-PCR.
    Ziegler BL; Lamping CP; Thoma SJ; Fliedner TM
    Stem Cells; 1995 May; 13 Suppl 1():106-16. PubMed ID: 7488936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice.
    Smith SI; Down M; Boyd AW; Li CL
    Cancer Res; 2000 Feb; 60(4):808-14. PubMed ID: 10706085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action?
    Olszewski M; Huang W; Chou PM; Duerst R; Kletzel M
    Cytotherapy; 2005; 7(1):57-61. PubMed ID: 16040384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of genes coding for proteoglycans and Wilms' tumour susceptibility gene 1 (WT1) by variously differentiated benign human mesothelial cells.
    Gulyás M; Dobra K; Hjerpe A
    Differentiation; 1999 Oct; 65(2):89-96. PubMed ID: 10550542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells.
    Georgantas RW; Tanadve V; Malehorn M; Heimfeld S; Chen C; Carr L; Martinez-Murillo F; Riggins G; Kowalski J; Civin CI
    Cancer Res; 2004 Jul; 64(13):4434-41. PubMed ID: 15231652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of WT1 target gene expression in stably transfected cell lines.
    Thäte C; Englert C; Gessler M
    Oncogene; 1998 Sep; 17(10):1287-94. PubMed ID: 9771972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function.
    Berasain C; Herrero JI; García-Trevijano ER; Avila MA; Esteban JI; Mato JM; Prieto J
    Hepatology; 2003 Jul; 38(1):148-57. PubMed ID: 12829997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilms' tumor suppressor gene (WT1) as a target gene of SRY function in a mouse ES cell line transfected with SRY.
    Toyooka Y; Tanaka SS; Hirota O; Tanaka S; Takagi N; Yamanouchi K; Tojo H; Tachi C
    Int J Dev Biol; 1998 Nov; 42(8):1143-51. PubMed ID: 9879712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1).
    Guglielmelli P; Zini R; Bogani C; Salati S; Pancrazzi A; Bianchi E; Mannelli F; Ferrari S; Le Bousse-Kerdilès MC; Bosi A; Barosi G; Migliaccio AR; Manfredini R; Vannucchi AM
    Stem Cells; 2007 Jan; 25(1):165-73. PubMed ID: 16990584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.